Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 31,51
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 33,97
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: Rarewaves USA, OSWEGO, IL, U.S.A.
EUR 36,32
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. The goal of clinical laboratories is to produce accurate information for clinical decision making in medicine. More than half of the medical decisions made depend on clinical laboratory tests. Patient safety represents an important and critical problem for laboratories. They need to assure that the information they deliver to physicians is accurate, and therefore safe for clinicians to use. Endogenous compounds can interfere with laboratory tests, decreasing accuracy and threatening patient safety. Elevated bilirubin (bilirubinemia) and elevated lipids (lipemia) are common conditions that cause significant interferences with laboratory results. Clinicians depend on laboratories to detect these endogenous interferences. Laboratories must have a means to detect these endogenous interferences, make decisions about reporting results, and evaluate their impact. Most clinical pathology books provide only an abbreviated introduction to the subject, or provide a long list of references, without the necessary foundation for evaluating their significance. Package inserts typically provide scant information. This book provides the empirical and theoretical foundation for these interferences, describes the clinical settings where they occur, and explains their evaluation and detection, allowing the laboratory to interpret the available data on interferences and make the appropriate decision to effectively report test results while protecting patient safety.
Da: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Germania
EUR 12,00
Quantità: 1 disponibili
Aggiungi al carrelloXIII,105 p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Sprache: Englisch.
Da: Revaluation Books, Exeter, Regno Unito
EUR 32,73
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 1st edition. 143 pages. 9.25x6.75x0.50 inches. In Stock.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 31,93
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 34,67
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Lingua: Inglese
Editore: Walter de Gruyter, Incorporated, 2012
ISBN 10: 3110266202 ISBN 13: 9783110266207
Da: Majestic Books, Hounslow, Regno Unito
EUR 46,16
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New. pp. xii + 143 28 Figures.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 39,18
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
EUR 52,53
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
EUR 55,30
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: BargainBookStores, Grand Rapids, MI, U.S.A.
Paperback or Softback. Condizione: New. Clinical Core Laboratory Testing. Book.
Lingua: Inglese
Editore: Walter de Gruyter, Incorporated, 2012
ISBN 10: 3110266202 ISBN 13: 9783110266207
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New.
EUR 60,36
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
EUR 61,42
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
Prima edizione
EUR 59,26
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. 2012. 1st Edition. hardcover. . . . . .
EUR 57,85
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Condizione: New. Softcover reprint of the original 1st ed. 2017 edition NO-PA16APR2015-KAP.
EUR 59,56
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Condizione: New.
EUR 57,84
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
EUR 59,54
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: Rarewaves USA United, OSWEGO, IL, U.S.A.
EUR 37,80
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. The goal of clinical laboratories is to produce accurate information for clinical decision making in medicine. More than half of the medical decisions made depend on clinical laboratory tests. Patient safety represents an important and critical problem for laboratories. They need to assure that the information they deliver to physicians is accurate, and therefore safe for clinicians to use. Endogenous compounds can interfere with laboratory tests, decreasing accuracy and threatening patient safety. Elevated bilirubin (bilirubinemia) and elevated lipids (lipemia) are common conditions that cause significant interferences with laboratory results. Clinicians depend on laboratories to detect these endogenous interferences. Laboratories must have a means to detect these endogenous interferences, make decisions about reporting results, and evaluate their impact. Most clinical pathology books provide only an abbreviated introduction to the subject, or provide a long list of references, without the necessary foundation for evaluating their significance. Package inserts typically provide scant information. This book provides the empirical and theoretical foundation for these interferences, describes the clinical settings where they occur, and explains their evaluation and detection, allowing the laboratory to interpret the available data on interferences and make the appropriate decision to effectively report test results while protecting patient safety.
Da: Kennys Bookstore, Olney, MD, U.S.A.
EUR 73,24
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. 2012. 1st Edition. hardcover. . . . . . Books ship from the US and Ireland.
EUR 65,74
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
EUR 66,03
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
EUR 76,81
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 105 pages. 9.25x6.25x0.50 inches. In Stock.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 34,95
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - The goal of clinical laboratories is to produce accurate information for clinical decision making in medicine. More than half of the medical decisions made depend on clinical laboratory tests. Patient safety represents an important and critical problem for laboratories. They need to assure that the information they deliver to physicians is accurate, and therefore safe for clinicians to use. Endogenous compounds can interfere with laboratory tests, decreasing accuracy and threatening patient safety. Elevated bilirubin (bilirubinemia) and elevated lipids (lipemia) are common conditions that cause significant interferences with laboratory results. Clinicians depend on laboratories to detect these endogenous interferences. Laboratories must have a means to detect these endogenous interferences, make decisions about reporting results, and evaluate their impact. Most clinical pathology books provide only an abbreviated introduction to the subject, or provide a long list of references, without the necessary foundation for evaluating their significance. Package inserts typically provide scant information. This book provides the empirical and theoretical foundation for these interferences, describes the clinical settings where they occur, and explains their evaluation and detection, allowing the laboratory to interpret the available data on interferences and make the appropriate decision to effectively report test results while protecting patient safety.
Da: preigu, Osnabrück, Germania
EUR 33,70
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Endogenous Interferences in Clinical Laboratory Tests | Icteric, Lipemic and Turbid Samples | Christopher R. Mccudden (u. a.) | Taschenbuch | Patient Safety | XII | Englisch | 2012 | De Gruyter | EAN 9783110266207 | Verantwortliche Person für die EU: Walter de Gruyter GmbH, De Gruyter GmbH, Genthiner Str. 13, 10785 Berlin, productsafety[at]degruyterbrill[dot]com | Anbieter: preigu.
EUR 57,68
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - The clinical laboratory is often known as a 'black box' to nurses, physicians, and surgeons, but this concise book removes the veil by covering all the pertinent aspects of the clinical laboratory. This book bridges between medicine and chemistry by offering an overview to a clinical laboratory's structure and function, the importance of laboratory utilization and test ordering, as well as pre-analytical, analytical, and post-analytical issues of importance to recognize in any clinical laboratory. An interactive FAQ and a detailed index are also available.